GLYCOSPHINGOLIPID BIOSYNTHESIS INHIBITORS FOR TREATMENT OF TUMOURS DEPENDENT ON THE ONCOGENE GOLPH3 AND ON ONCOGENES OF THE GOLPH3 CLUSTER
GLYCOSPHINGOLIPID BIOSYNTHESIS INHIBITORS FOR TREATMENT OF TUMOURS DEPENDENT ON THE ONCOGENE GOLPH3 AND ON ONCOGENES OF THE GOLPH3 CLUSTER